All News

Novation is offering a new service to help member hospitals recover their supply chain dollars.

Speakers at the AMCP meeting give suggestions on how more hospitals can make use of the 340B program.

The revision emphasizes training and competency of pharmacists.

Drug samples should be replaced by vouchers to reduce drug diversion; chemistry courses are critical to the education of pharmacy students.

DEA's new rule allowing multiple prescriptions for Schedule II controlled substances could engender greater Rx drug abuse.

The risk for fatal medication errors is highlighted in an important new warning within a revised produt label for Heparin Sodium Injection.

Combo drugs are driving drug development in hypertension these days.

Regional groups are forming to set up standards for experiential training of students.

Does the lactose content of medications pose a problem in patients who are lactose intolerant?

Diabetes is taking a greater toll

Nine Miami defendants in strike force cases sentenced for Medicare fraud

Sargramostim withdrawn from market

NCPA offers free respiratory care certificate program

Biomarkers may be on the verge of changing medicine, but they need a push.

A safe workflow that's ingrained in pharmacists can do much to reduce the likelihood of drug errors.

CVS/Pharmacy sponsors magazine for top-tier healthcare purchasers

OTC allergy drug battle heats up

Moxatag is the name of a new once-daily amoxicillin product for pharyngitis and tonsillitis following strep throat

New CDC data show that while there are 17 diseases against which the public can be immunized, adoption rates are low

In a new labeling change, Schering-Plough's Claritin can now treat both indoor and outdoor allergies

Outcomes Pharmaceutical Care has been chosen by Senior Whole Health to provide medication therapy management to its drug plan

Baxter issues voluntary recall of heparin

Fire temporarily closes UIC College of Pharmacy

Wyeth, Teva extend standstill period on Teva's launch of generic pantoprazole

Women's supplement usage declining

Aliskiren and hydrochlorothiazide combination approved

Tibotec's Intelence is approved for use with other antiretrovirals to treat HIV

Daiichi Sankyo's Welchol, formerly approved to lower LDL-C, has been cleared to reduce blood glucose levels in Type 2 diabetics